Can mobilization of bone marrow stem cells be an alternative regenerative therapy to stem cell injection in a rat model of chronic kidney disease?

Abstract Chronic kidney disease (CKD) is a priority health problem affecting 36% of Egyptians. Adipose‐derived mesenchymal stem cells (ADMSCs) have multidifferentiation capacity and the ability to restore several types of cells including damaged renal cells. Granulocyte colony‐stimulating factor (G‐...

Full description

Bibliographic Details
Main Authors: Shereen Morsy, Mona F. Mansour, Mohamed Abdo, Yasser El‐Wazir
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:Physiological Reports
Subjects:
Online Access:https://doi.org/10.14814/phy2.15448